KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Change in Cash (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Change in Cash data on record, last reported at $6.8 million in Q4 2025.

  • For Q4 2025, Change in Cash rose 211.65% year-over-year to $6.8 million; the TTM value through Dec 2025 reached $10.4 million, up 113.21%, while the annual FY2025 figure was $10.4 million, 113.21% up from the prior year.
  • Change in Cash reached $6.8 million in Q4 2025 per CRL's latest filing, down from $24.5 million in the prior quarter.
  • Across five years, Change in Cash topped out at $237.9 million in Q1 2021 and bottomed at -$243.5 million in Q2 2021.
  • Average Change in Cash over 5 years is -$856100.0, with a median of -$549500.0 recorded in 2021.
  • The widest YoY moves for Change in Cash: up 267.23% in 2024, down 138085.09% in 2024.
  • A 5-year view of Change in Cash shows it stood at $19.8 million in 2021, then surged by 127.36% to $45.0 million in 2022, then soared by 163.93% to $118.9 million in 2023, then tumbled by 105.11% to -$6.1 million in 2024, then skyrocketed by 211.65% to $6.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were $6.8 million in Q4 2025, $24.5 million in Q3 2025, and -$47.0 million in Q2 2025.